| | | | | | . 10 . 20 . 30 . 40 . 50 . 60 . 70 . 80 . 90 . 100 . 110 . 120 . 130 . 140 . 150 . 160 . 170 . 180 . 190 . 200 . 210 . 220 . 230 . 240 . 250 . 260 . 270 . 280 . 290 . 300 . 310 . 320 . 330 . 340 . 350 . 360 . 370 . 380 . 390 . 400 . 410 . 420 . 430 . 440 . 450 . 460 . 470 . 480 . 490 . 500 . 510 . 520 . 530 . 540 . 550 . 560 . 570 . 580 . 590 . 600 . 610 . 620 . 630 . 640 . 650 . 660 . 670 . 680 . 690 . 700 . 710 . 720 . 730 . 740 . 750 . 760 . 770 . 780 . |
# |
Score |
Template |
Links and tools | %id | First |
MSGNTHGLSWFPHFPDKFVSWGQEIHLYEVRRKDDHSQKSRLPYISVNYLANESRYQYARCVAASYHSDQPIIAVGLADGKVGICNFRDTYDSSWEYTPRQQRMCTCLAWNELDANILAIGHDRHRNDTCITIWDIERGVPKETANFFGVGESANSICWDRNHRTVIAGMSQKMIKLFDLRQSNATCQSIQTKTVQGLSVSPNGNYLCSYVDSVITLWDPRNIKSPLRQIQSSKNHLQIAWCPTRTSLLSSLQRDSSYITLYDIRSVDTDNSGEIYHVKRQISPFPARYQHSGKFSFVNCLSWHSRDFERALLLADALNILDFRLPATLHTAHSNRRKLPLLMQRPLYTPASPTSTAATPTQQQPTSSCSTNSGSSLDFSTPGGSPFNVDLLKPELFELDLVDETRQRALEDYGIKPDNKRFGELHLTPYLRNVWSTLNNVYSEDRLTGLKATLGINLGHTSEALMASSRIESQVLQWPEGINNSNKLICYRSEQRDLALQLCGWAFEQELDRFIDQLYANKEYSRAAMICVFHLKIFHACNILSSAADNMRDPSMYRITVIALSSFNADRCSSTWRNQRSSANMQIHDPHLRAVFSFLTMEKDNFDAVLKEEGVSLSDRMAFACKYLSETKLADYVAQQIQAAIDGGDLNGLLLTGESQDGIDILQSYMDTSFDVQTVALVAINYFRQELFEDKRIQYWIASYLDHLNSWGLWEKRAELDIKIESIRPSSRSSRTVFLSCNFCGKSVSNALLDEPRPRSTTTSTNRLSSCPSCRKPLPRCSLCL | Last |
1 | -21.900 | PF16529.5; K7INF6_NASVI/86-417; WD40 region of Ge1, enhancer of mRNA-decapping protein |
ali follow.. |
10 | 2 | ......................................SSKVKLKNIVDFTWEHRYYVGQLLAVHM--SGKYLAAGNGNGVVRVVNKELEQRTLIR---GMRGLIQDLAFAHVSNPILACVDY----TGSLFVYSIEATSSELIVDADDPSPMSHRVIWCPEVSKLLALTRGSKAELWSIAAASRLEIYQHSGTIVEATFSPDGTALATASDGEVKFFQVYLHGATCGQ-HDGKPISSLFFLDDHKRFAVTGCDNNSELKVWSCELWTCLQTIKFSP------------MPNTQKTPVLKARLDLAASYLLLSDIYNKVLYILSISKDSE....................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
332 |
2 | -20.800 | PF08553.10; A7ERL5_SCLS1/439-794; VID27 C-terminal WD40-like domain |
ali follow.. |
8 | 2 | .VNSQLAVGYKHDRS--FVVRGSKIGVFKHTPNNNLEFSTNISKVQ----TPNGKLFSPKKVMLHAEDTNMILQDERNPNSLYKMDLEYGK---IVDEWKVHDDIPVNTFAPESKFAQMTGEQLGLSRNALYRIDPRLAGNKLVDSELKQSKNDFSAAATTEKGYIAVASNKGDIRMFDRLGINAKHIPALGEPIIGLDVSADGRWVLATCRTYLLLIDALQKDETGAALSFTPARFNTGEGLSETSIITA---TGPFIVTWNMKKILRGSKDP--------------YSIKRYAEEVKADNFKYGSDKNVIVALPNE................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
333 |
3 | -20.200 | PF15492.6; NBAS_DANRE/79-359; Neuroblastoma-amplified sequence, N terminal |
ali follow.. |
12 | 2 | ......QLVLASNGKLLAVVQDQCVEIRSARDDFGSIIGKCQ--------VPKDPNPHWRRVAWSH--DCALLAYADSTGTVRVFDLMGSE---LFIIPPAMSFPGDFSYAAAGLMFLEYTGSAQTYSGQLKSYLVSVGTNQGFQENHHYSNGITTAIYHPGHRLLLVGGCESGDSDVSRASQCGITA-------RVLSGLPHYKQVTSYEDDISSFFKMPSFRLFSRHNGEQDGVFRMSLSPDGTILAVI--HFSGSLSLWDIPSFKLRGSWKQEEQPGFDEINP---------------EW.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
281 |
4 | -20.100 | PF15390.6; G1PMX6_MYOLU/2-677; WD repeat and coiled-coil-containing protein family |
ali follow.. |
9 | 56 | .FEHVYGVSWAPPGIAPLLAVQHKQHVTVWQLCPNTTETSKPLLSQTCEIREPRP-VLPQGCVWHP--QSAVLTVLTARDVSIAHN-VHCDGSRVKADSSAQGLIHCACWTQDGQRLVVAVGS----SLHSYIWDSAQKTLQRCSFVLDVLSDVRSIGAAVDS-QVVLATELPIGKICGLNASETFGVPPSSEDTCLYTSPVSDEMPSVDKGAASCGTNSDTSVSPFSSRSDPLDLTHIRFNGSKSESNALICLRKK-----NYLAGTDLDSSHLILVTFAQVVTQAKKVTIPGILVPDLIAFNPKAKVVAVASNTCNIIFIYSVIP---------------------AVMPNIQQIQLESGERPKGICFLTDKLLLILIGKQKSTDSTFLPSSKSDEYVIRLTVREVTLKEEFPVTVSENQSGYTTLSALLNKAERKKPIESLSPDICHQNLTANSSSQGGRPGSTFIKEIKRPPSSVCDDSIALETREAEPVDGSATLPKTSSTPDFTSTLGPLNLPPRKNLQREKEACQLSKELEILSRKLMEVQRSLSE----------LTDFLRNG-----KKSSPVYPLSEDLPYVHISYQKHYSVESVVEKLLCHGKLRLS-QQTFGL---------TLVEMLHDSILLPADSEGFILTFTAKQEILV........................................................................................................................ |
676 |
5 | -19.200 | PF16756.5; G7Q0Q7_MACFA/836-1183; Partner and localizer of BRCA2 WD40 domain |
ali follow.. |
9 | 80 | .EVPVLQIVPVPDVYNLVCVALGNL-------EIREIRALLCSSDDESEKQVLLKSGNIKAVLGLTKRRLVSSSGTLSDQQVEVMTFAEDGGGENQFLMPPEETILTFAEVQGMQEALLGTTV----MNNIVIWNLKTGQLLKKMHIDSYQASVCHKAYSEMGLLFIVQSPVFQLIVINPKTTLSVGVMLPGQAGRFLEGDVKDQCAAAILSGTIAIWDLLLGQCTALLPPISDQHWSFKWSGTDSHLLA--GQKDGNIFVYH.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
348 |
6 | -17.700 | PF17005.5; J8ZY85_EDHAE/6-349; WD40-like domain |
ali follow.. |
11 | 1 | ........................................................EELYSIDISK--NGQLIAFGGKSDTLTLAKFPSLI--SITSETSFTDSIIYVKFILNDVILCAT------LDGNLHVLENGEEV-----DNRDLEEDISFIDVIND--LVVVGTNKGSIHIFSQDLQNEILFVGQHSEIRDIKII--KGKLYSLSESHYMIFDLFTQGTLYKRSYKDFRTFNIV-CTALVDDYLVSGGSGFSLTIINIKSPSNCFNLRFNVEGISKIVRLSKNIVGIATFCGKIAIGDVRSGETFKFYDGVGIIYDMKFFRNYVAVCGNAG................................................................................................................................................................................................................................................................................................................................................................................................................................................................ |
292 |
7 | -16.600 | PF04762.12; A5DLM0_PICGU/1-950; IKI3 family |
ali follow.. |
10 | 69 | .DASLKSFAHFVDS-CQLVFAFSNGDIITATYDPTAPDPDTTIVEIVGSID-----AGIWAAEWSY--DEETFAVLTAEYKLVLLSRQTVGEIEQGILSTADLGVNTISWRG-DSAYLAVSTGEKYDRRVIRVFS---REGELDSVNEAVDGLEHNLAWRPQGHIASTQRHTDGIVFYE-HGEFNSRLDPDTNTIISLHWSSDSSVLAIDNTNRIQLWTTKNYHWYLKQEISFAEISFLKFHPEKPLHLMVGCPDSGTVMVTD------GSELKVTPMAVANVPPPMAYREIEIGECITDTACSS-SNELVVALTNNQNLASIAVPFEGPSKVLKKQSIAFARSTAAVLVDGDVQKVLFFDIDLDAKITFKDSMDTPAKIVLLKSSSNYDSWVLESSNGTVYRHINDEFQPVTRFPQLCRDFEMAVQDNNISAFGISANGKLFANETQICSGVTSIKVTENEKYQEFDEVAKTGSDERIRQIEQGSLLVTVMPSKYSVVLQA-G-----NLERVVRDFIRNKQFGEAFMACLHDYDRELFFDNVELFVKQINKVEHLDLFVSCIH--EEDVTKTKYRDTLGEVDDISANKICDAILKVLCKPAYFLQTIVTAYACQSPPNLTEALNLINSLQNSAQAESALEHLCFLQDVLKLYKTALG-------------IYNVKMTLAIAQKSQ-----MDPK------EYLPFLQNLH--RRRFLIDDFLKNHVKA....................................................... |
942 |
8 | -16.000 | PF08662.11; A0A0D1CK95_USTMA/232-427; Eukaryotic translation initiation factor eIF2A |
ali follow.. |
11 | 10 | ..........................................................................................................QIKWNKAGSALLFMTGKSYYGETNLYLMSVRGDFDCRVA--LDKEGPIHDFEWNPNSKEFIVIYGYMPAKAVLFSHRVNVIAELGTQPRNFVAFNPQGRLFCIAGSGTVDVWDRQELSKGKIFSMDASNSSVCQWSPDGHFLLTATLSPENGVKIWHCTGQLVHVDMIDE............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
192 |
9 | -15.400 | PF11768.8; A7S6S2_NEMVE/1-544; WD repeat-containing and planar cell polarity effector protein Fritz |
ali follow.. |
8 | 83 | IPDHVCHAVLT--DSFVIFSFKDKAKLFFVSLGKKPSLDFKKLERLSALDPKMSFAELPRRLSVNQRQEMVLVTGERDRSNIIIFGISGSKLEILCYC-RTECDPVHVAFSFNQPHHVHTLPGSDDSSIDNCIYEYTKNKIERVVTTIPINAPVAVQARNHAEDKLLLGCQDGTLMLYDGHRKI-TQMTKAAVTPHHIRWHPADAIILVCSRGEIQVFDMALAPVMIQLLSENPQLDKVSWSCEAP........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
369 |
10 | -14.500 | PF07433.11; Q1GEI0_RUEST/56-356; Protein of unknown function (DUF1513 topsan) |
ali follow.. |
9 | 5 | ........................................................DRGHAASAHPTRPEAVAFARRPGRFADVIDCRSGAQLARLEPPEGHHFYGHGVFSPEGEVLYTTENDYARGAGVIGVWNAGDY--HRIGQFSSGGIGPHEMLLRRDAPGLVVANGGIETAKLNIPFMRPNLSYLRLSSIRHIAVRSDGAVGFAMQVPIVGLHQPGSAEDDPRLRNLNGYGGSIAFSGDET-AIAVTSPRGGVVQVMDCTSGALQAEHALSD............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ |
257 |
11 | -14.000 | PF12894.7; B6QBR5_TALMQ/41-156; Anaphase-promoting complex subunit 4 WD40 domain |
ali follow.. |
11 | 1 | ...........................................................................................................LTYCP-TMDLIALATE----DEQLYVFRLNSADLAGDPYLDEVKGEIRGVRWKNDGRLLAVADAENKLRIISSYTGKTVHFSCLPHEAEGHSSSPNESTKDPKDRITCIGWGVN.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
116 |
12 | -13.600 | PF17034.5; YAG1_SCHPO/778-905; Zinc-ribbon like family |
ali follow.. |
33 | 1 | ....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................CNFCRKPIFPFSNRQRGVSKAGPAKHLGKSCPHCGQPLPKCSVCG |
55 |
13 | -12.600 | PF08728.10; E7KI28_YEASA/125-948; CRT10 |
ali follow.. |
10 | 37 | .......LQFKNNGSYSFLAAGQCVEVHNFDVLLNNFRNSSYVKFKDTQFNSIPELCSINFMKICNFMHQDFLLACGDNGIVYIWEINKVIKIFNKFTSDILGGVEESCWSINGIIYIAVG----HNKPGVTVFAFDKDVKKERPLDLPSSHNVPCVNFVPNSKTLSYCSIFGNVVTVKLKEHDCTITQFFGDDLWTITPLTKKDFAKVDNFESLNLYQDGFKESMLYSICRDDFLLGYY-NAYLSGNFGIGTLLNQFVPVTDLRLTSSAGIPDEVIPLRFTSFDRNYTTTGSIKYEYSREDFALILHAGDLDDMNDAVTKNTSCEQHLHQWTFWEDSGYKHYRATERGFSKYKDIINTFPQLITPSGRNKTSQYQNTSGRKICEPFTYKLTDLENDIEDISREFNRSIRNLKMDKQRQLRTSKEFKSLSSVNHLPNIESGNFLWYNTDAAADWRTLFGKDLNTVLKDPEICSLQLNSTEEDDVNSDPENEESGSSLT-------SFQRRYRDTEQRAHLKSESQKSWGFHNYVRNVKRLLESVVPGSEDSPLGYQLSEMHDEFFFLTTAHRLVLMKANPLIIISATHH----EIFPLDGVVT-----CASKSLLQALNRINFVCHI---KELNCIA------ASQLGLISLLRLTSFRQEYILGWEVQDPVNPSPECRCNRNLFDAPMYGADGESSDTYCGVCDVYF-----MGDICGLDYTYASDSEELKRKGYATL.............................................. |
811 |
14 | -11.400 | PF11635.8; MED16_ASHGO/153-934; Mediator complex subunit 16 |
ali follow.. |
7 | 11 | ..STILDFQWIGNQKPSVAQRDRTNNIFKNQMHQCPPY------------------------VFHPASIKSACIAIRRNGYIDLWYQFSNTLDFKKISLQLSKDKEQIAHTDKEQCFLIGVFS--NVAKSFAFYELLINWNVNTTNQAMFHDPKLTLRHILRVRPDALGPNGELLKLENFHVISKTALPGTRPEILIS---------LGTERSLVRRFQMVLSNPDMVFLTFDSKIMDIQ--SHSLDALVCFRLHNGRFQLYNRHTWAVESETADAKQIGGYTKDTIISPLLPPADAIEWCAISPSS--GIILKLKCKPQPTFYALEQSVLTDPSRDIVHATA-------------------AFEFVRFNNMIHSGEDLAIAAKTHVFRLQRLSEERAVNFIASVIGAILSGIHFDGPKEILEKLLQSKAIQKLGSHLKNKNVYSMAYASMKLRSINLAMNGVARNVHAMIQHTAVVNSLPNGRAFQFAFSKQDLIYSLIPSVNWFVS--TQQLIMLVNNPMDNTHSLVLGILSCITTRHLKVILELKN-----------MIGLITKFPETTYTVLNESSRFLRKALGDS-LEKFEVFLNEINNKFLSLLDDHG---AQSMDREPSFMVKAEIPPALGHVREFLLSF-------AGSALLAQTNLAEVFFASTHRIFDHQHFHPSVANLLQPPEKGLVVDDAILPDACRGSS--FSPLDYDDISSEWVDMSALVR----RCVRCGCVTRAGNPVAKNNTILETSIVTKRWTALYSR---YC-QC. |
776 |
15 | -10.600 | PF05280.11; Q63PR3_BURPS/1-173; Flagellar transcriptional activator (FlhC) |
ali follow.. |
18 | 1 | ...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MASKSVVVEVKELAIELIELGARLQLLETNLSRDRLIKLYKFMTWQPNIHSSLFYNIYRFMREHGGCDSIQSIVKAYRLYLEHVGLSDDEAVLSLTRAWTLVRFFDSGMLQMPCTRCGGHF-----------AHAHDPHHGYVCGLCQ.......... |
161 |
16 | -10.300 | PF12234.8; C0NL69_AJECG/639-1280; RAVE protein 1 C terminal |
ali follow.. |
9 | 1 | ...............................................................................GRVRTWTAKVDKQNLTSTVETGICNPSLASGASMRKAAIID-----QDRTRLTIWDTYGAQ--EFEEKFPQHDIIKDLDWTSHTQSILSVGFPHKVVLMSQLRYDYLDAGPSWTQIREIS----------------------------IRDLTPHPIGDSCWLGNGNLVVGS----GNQLFVYDKHIELSNRLVANLRLPARQIYVDLFGVVSRLNGTLP--VFHPQFLSQCILSGKSNLVHLILTSLYRKLIFYTEGDELDGFLDIPLEDIYQNEDAMKKVHWKEMPSSYGDFTTDCESSVVDETLGTALNENLMRVALPQLT------------------------STEQFRLVNIIECVATVDKHRRSMDDNAARYLLFFRQHVLRRSQGL-------------------PEQPTVSWREIVWALHSDSHEILVDLVSRQEHAKESGIFMWITDLNCLRAQLEVVARKSDEKNPIDCSLYYLALRKKSVLQGLWRMAGWNREQ-------SATQRLLSNNEPRWKTAALKNAYALKRRFPYAAAFF-------------------------LLADHLRDAVYVC---MNQLQDVQLAVAIA------RAYEGDD-----PVLKEILEERVLVDAASEGNRWMATW.......................................................... |
543 |
17 | -9.760 | PF04841.13; VPS16_SCHPO/8-420; Vps16, N-terminal region |
ali follow.. |
13 | 17 | ...AIGKAEWEYIDPVMFAVAPCGGAIAITRSESNLQSNYKYDQVPMYSICVFCDKTSLVGMGWNENEE---LIVVSKQGQVRVYNLLGEFHQFSLGKGVENIGIRECQFSEGGVFALL------QNDTFISITGFEEPWRKTYASIPFNTLALIPNPFSPDLGMDIVVTVGPHILQIDEQDSQ-LHSISSLQHVSHISISPNARYLALESVGKVRVISSDFSKELLPETVAEASLKQMAWCGND----AVVLVHENLLTLVGPFGGS..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
293 |
18 | -9.540 | PF10647.9; D1BCN8_SANKS/337-589; Lipoprotein LpqB beta-propeller domain |
ali follow.. |
7 | 22 | .AADPTALAISPDG-AQVLFRSGRTSIRTVATNAEPSQVLAG--------------KDLLAPSVDR--FGWMWSGDMLAGSPLQVVSPDGVVTAVPADWLDGRKVESVQVSRDGARIAVVSSDTSGTRIDVAGIVRGDTDLSDALVAGAAVVGASQVVWVDESTLAVLAGQSSGARTHLVPLAAHSEALSGVEGAEWIASGRGRRAYVVTADGELFNWT...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
229 |
19 | -9.280 | PF16755.5; G8ZS05_TORDC/24-383; Nucleoporin or Nuclear pore complex subunit NUP214=Nup159 |
ali follow.. |
9 | 13 | .YTSLQNLDISNEKCRYVATSGGKVVIGDLQSLREFIQNDENTEISFLWERELKDVMMVKF-----SVSEDVVIV-CKDGSVYTVDQNS-----LNDPKNIYKFDKALSQAQLFQSSLLA-----TIDDQLFSYNLAQSSLSSSI-----ADNLASFDIMDNELYLLLDDYSVQVKNLQNNHETIKKLSAPQEHPNIIKVLNKNQLLLVFGEKVSETDEDVMYDHKFFIVDHSADQPTFEPVPEYEVINVLASACSSEVTIQPSQDSERAVLPISKTTDNDTNPIGVSLDVSTHGVITDPCPGVDKIDRLIYILNDEGNLQIVGL............................................................................................................................................................................................................................................................................................................................................................................................................................................................................ |
359 |